Catalyst Wire Dossier Catalyst Wire Dossier

ParActin®

· Vedic Lifesciences Pvt. Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ParActin®, covering 2024-06-17 to 2025-05-31. Get the full timeline:

Most recent: Clinical Trial Update: To Assess the Effect of 336 Days Exposure of Paractin® on Pain & Disease Progression in Patients Suffering From Osteoarthritis of Knee Joint. [NA]

See pricing